Trial intelligence / Profile preview

OCTOPUS: Perioperative Octreotide in Endoscopic Papillectomy for Ampullary Tumors

jRCTs051250180Recruiting

Start
Mar 2026
Modality
Peptides
Countries
1
01

Overview

Randomised trial of octreotide in duodenal papillary cancer, Duodenal adenoma (DA) and ampullary adenocarcinoma (2 arms). Started Mar 2026; status: recruiting.

02

Drugs

octreotide
03

Conditions

duodenal papillary cancerDuodenal adenoma (DA)ampullary adenocarcinoma

Beyond the preview

Go deeper on jRCTs051250180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051250180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call